Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

CSE:HUGE - Post Discussion

FSD Pharma Inc > FSD pharma accomplishments or the lack thereof
View:
Post by Walter333 on Sep 25, 2021 10:40pm

FSD pharma accomplishments or the lack thereof

Failure of the world's largest hydro grow op, the 201:1 RS, the constant dilution by any and all forms of management since inception, the shelving of micro PEA and scrapping of trials, World class extractions failing at extractions and turning into a delivery company.
Comment by DavidRosenberg on Sep 25, 2021 10:48pm
  PEA isn't scrapped bloom burton advised FSD Pharma that doing covid19 clinical trials wasn't the best idea  $ELYM is doing phase 2 PEA trials results due first half of 2022 yet is 400M+ marketcap company  FSD Pharma's competition it's wise to wait out and see those results before spending money to start another indication  if ELYM has good results it ...more  
Comment by Mil_Man54 on Sep 25, 2021 10:55pm
Hey Waletr.....whats's your opinion of Rosenberg comapring FSD to TRIL and ELYM......I say he's trying to tranfer the success of these companies to FSD because they would share the same parking lot at UHN......and notice how he completely avoided evrything elsr you said and focused on the PEA....like I've said before he cherry picks his info to fit his pump.....
Comment by Walter333 on Sep 25, 2021 11:22pm
There's leaders and followers in every sector with the differentiating factor being the caliber of management. A company can have a blockbuster product however without the right management to execute it remains worthless.
Comment by Walter333 on Sep 25, 2021 11:02pm
This isn't ELYM or any other company, it's FSD stop kidding yourself. No hate, no jealousy, just facts. Sitting back to leach off others success seems par for the course with this company. Thanks for the luck but you better keep it. When has this company ever been on the right path?
Comment by DavidRosenberg on Sep 25, 2021 11:03pm
  It's in the right path now In my opinion  Stifel did $ELYM underwriting I believe and also invested into it  yes FSD Pharma and ELYM have the same PEA drug  offcourse results from their clinical trials matter 
Comment by Walter333 on Sep 25, 2021 11:15pm
Please explain to me as I'm genuinely curious as to your logic here, just due to the fact others in the same sector are at such valuations then by default this company must be as well? There's so many differentiating factors to consider when comparing companies and their valuations. So by your logic if AD bought the local mom and pop pizzeria that he already had a stake in previous to it ...more  
Comment by DavidRosenberg on Sep 25, 2021 11:21pm
  not by default but rather by indication  also depends what we are talking about if psychedelics specifically marketcap is enormous  PEA and opioid sparing for pain could be another huge market  results from competition could re enforce or go against FSD201, so let's see if positive or negative in 2022 if results are positive , I bet you biotech analysts ...more  
Comment by Walter333 on Sep 25, 2021 11:03pm
Short interest here is only 3% of the float. You can stop pumping reddit and other social media forums for a squeeze, the numbers just aren't there for it to happen, nice try though.
Comment by Mil_Man54 on Sep 25, 2021 11:08pm
We've been saying the same thing to Rosenberg for weeks now but he still pushes the shorting fairytale and accuses us of being the shorters.....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities